Breaking News

Geron Corp. Grants License to P&G

November 22, 2005

Biopharmaceutical company Geron Corp. has granted a non-exclusive license to Procter & Gamble relating to Geron’s human telomerase reverse transcriptase (hTERT) technology for cell research applications. Financial terms of the agreement were not disclosed.
P&G plans to use the technology to create immortalized cell lines from certain types of skin cells to study the regulation of cell function and to develop biological tests for screening purposes.
Cell lines immortalized with hTERT technology can proliferate indefinitely while maintaining normal physical and biological characteristics, according to experts. Executives said this means P&G will be able to conduct repeated or long-term studies on the biology and functin of the cells.
blog comments powered by Disqus
  • What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 24, 2016
    Euromonitor weighs in on the implications for consumer product companies.

  • Henkel Grabs the Sun

    Henkel Grabs the Sun

    Ian Bell, Euromonitor International||June 24, 2016
    Euromonitor's Ian Bell on the impact the purchase will have on the US detergent industry.

  • To The Max

    To The Max

    Melissa Meisel, Associate Editor||June 20, 2016
    Velvet 59 is on the rise at locations like Ricky’s NYC.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.